Searched for
COVAXIN DEAL
Covaxin booster enhances antibody response against Covid variants including Omicron: StudyThe government on Saturday announced that precaution dose of COVID-19 vaccines will be available to all aged above 18 years at private vacc...- Gavi and India's Bharat Biotech discuss possible COVAX use of Covaxin"We are in discussion with (Bharat Biotech) as we consider the overall needs of the COVAX portfolio in 2022. However, we have no agreement ...
- No shortcuts taken for Covaxin approval, says Bharat Biotech chairmanBharat Biotech chairman Krishna Ella on Wednesday said that no rules and regulations were tweaked while Covaxin was granted emergency use a...
- Experts fret over delay in WHO nod for CovaxinThe Indian Council of Medical Research (ICMR), which collaborated in developing the Covid-19 vaccine, said the issue is between the WHO and...
- After suspending EUA request, Brazil now shelves import authorisation of CovaxinAccording to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decisio...
- Brazil suspends clinical trials of Bharat Biotech's Covaxin“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studi...
- Followed all steps for regulatory nod: Bharat Bio on Brazil dealBharat Biotech said it has followed a widely accepted ‘step-by-step’ approach towards contracts and regulatory approvals in Brazil and not ...
- Brazil to suspend $324 mn Covaxin deal with Bharat Biotech amid graft probeBrazil's Health minister Queiroga said his ministry is going to carry out an administrative investigation to verify all aspects of the issu...
- Bolsonaro in a bind over suspected graft in India vaccine dealThere were several red flags, according to Miranda, who testified Friday before a Senate panel investigating the government's handling of t...
- Shortage of vaccine sees Delhiites in UPThe CoWin portal to book vaccination slots doesn’t reflect the Uttar Pradesh government's decision to reserve vaccines for the 18-44 age gr...
- Centre inks deal with Hyderabad-based Biological-E for second Made-In-India Covid shotThe vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...
- Delhi floats global tender for 1 crore Covid-19 vaccine dosesIn the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authorit...
- Hester Biosciences jumps as company inks Covaxin pactThe scrip jumped 14 per cent to Rs 3,099 in early deals, but gave up some of those gains to trade at Rs 2,914.75 at 11:00 am.
- Bharat Biotech to ramp up Covaxin production by additional 200 million doses"The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Adar Poonawalla transfers entire Panacea Biotec stake worth Rs 118 cr to Serum InstitutePoonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 per share to Serum Institute in a block deal on the BSE earlier today.
- Why it is not that easy for other vaccine makers to just start producing CovaxinExplaining the need for a BSL-3 facility to make Covaxin, Dr Rakesh K Mishra, former director and now advisor of Centre for Cellular and Mo...
- Haffkine Institute gets nod to produce CovaxinThe Maharashtra government had sought permission from the centre in March seeking the Centre’s nod in getting Haffkine to have a deal with ...
- Panacea in talks with Bharat Biotech to make CovaxinExperts have called upon both companies to ramp up production and have asked the government to approve the use of more vaccines in the coun...
- Telangana yet to roll out the 'local' vaccine Bharat Biotech's CovaxinHyderabad, Telangana has still not rolled out Covaxin, developed by Hyderabad-based Bharat Biotech, apparently due to fact that the Centre ...
- India to treat homegrown COVID-19 vaccine same as AstraZeneca'sAdministering Bharat Biotech's COVAXIN, a move cheered by nationalist politicians, has worried some health experts who consider it rushed, ...
Load More
